Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical Biomanufacturing Facility
Oxford University
Churchill Drive, Headington
Oxford, OX3 7JT

Reception: +44(0)1865 744845

Map of the Churchill Hospital site

A number of vaccines being developed by Jenner Investigators are manufactured to GMP clinical grade at the University's Clinical Biomanufacturing Facility.

The Clinical BioManufacturing Facility produces biological Investigational Medicinal Products (IMPs) according to the principles of Good Manufacturing Practice (GMP) for early phase clinical trials. It has a Manufacturer’s Authorisation for Investigational Medicinal Products from the Medicines and Healthcare products Regulatory Agency(MHRA) and has 3 nominated Qualified Persons(QP).

The CBF aims to provide the link between academic research and clinical drug development, to allow Universty researchers and private sector collaborators to make rapid progress into clinical trials.